Clinical Trial

Prognostic Value of PLR On Cardiovascular Complications in Chronic Hemodialysis Patients

Completed
View on ClinicalTrials.gov →
Summary
Prognostic value of platelet to lymphocyte ratio on cardiovascular complications in chronic hemodialysis patients this study was done to determine the prognostic value of PLR on cardiovascular complications like vascular calcifications and atherosclerosis in carotid and coronary arteries in chronic hemodialysis patients
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-03.
Trial Details
NCT Number NCT07519785
Lead Sponsor Minia University
Conditions Cardiovascular Complications in Hemodialysis
Enrollment 80 participants
Start Date 2024-01-04
Primary Completion 2024-06-04 (estimated)
Study Completion 2024-08-04 (estimated)
Updated on ClinicalTrials.gov 2026-04-13